China's health regulator said on Monday all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical that could pose cancer risks.
from Reuters: Health News https://ift.tt/2K74TSX
No comments:
Post a Comment